SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-18-000158
Filing Date
2018-02-16
Accepted
2018-02-16 13:25:10
Documents
2
Group Members
ORBIMED CAPITAL GP V LLCORBIMED GLOBAL HEALTHCARE GP LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 ss80326_sc13da.htm SC 13D/A 149660
2 JOINT FILING AGREEMENT ss80326_ex9901.htm EX-99.1 40705
  Complete submission text file 0000947871-18-000158.txt   191959
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89486 | Film No.: 18620475
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences